Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients

NCT01830491 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease (CAD)

Interventions

DRUG: Clopidogrel
DRUG: aspirin 100mg

Sponsor

Hanmi Pharmaceutical Company Limited